Mereo BioPharma Group plc (AIM:MPH)

London · Delayed Price · Currency is GBP · Price in GBX

26.50

-0.50 (-1.85%)

At close: Dec 17, 2020

Mereo BioPharma Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	30.12	40.99	69.8	57.42	68.18	126.91
Short-Term Investments	-	-	-	-	-	0.77
Cash & Short-Term Investments	30.12	40.99	69.8	57.42	68.18	127.68
Cash Growth	-46.34%	-41.27%	21.56%	-15.78%	-46.60%	298.48%
Other Receivables	1.92	1.98	3.25	3.73	2.31	2.46
Receivables	1.92	1.98	3.25	3.73	2.31	2.46
Prepaid Expenses	0.77	0.38	0.27	0.97	3.78	3.79
Other Current Assets	0.59	1.66	1.44	1.64	0.92	0.55
Total Current Assets	33.4	45.02	74.76	63.76	75.2	134.49
Property, Plant & Equipment	1.06	0.38	0.98	1.65	2.22	3.43
Other Intangible Assets	0.26	0.52	0.64	1.09	-	33.26
Total Assets	34.71	45.92	76.39	66.5	77.41	171.18

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.21	1.43	2.68	2.35	3.49	3.09
Accrued Expenses	3.06	2.35	4.57	5.75	5.64	5.44
Current Portion of Long-Term Debt	-	-	5.54	-	13.33	-
Current Portion of Leases	1.03	0.2	0.71	0.65	0.56	0.84
Current Income Taxes Payable	-	-	-	-	-	2.06
Other Current Liabilities	0.38	0.33	0.36	0.74	1.36	5.55
Total Current Liabilities	5.68	4.3	13.85	9.49	24.38	16.98
Long-Term Debt	-	-	-	4.39	-	19.48
Long-Term Leases	-	-	0.19	0.91	1.48	2.38
Other Long-Term Liabilities	0.39	0.7	1.39	1.18	0.16	13.18
Total Liabilities	6.06	5	15.42	15.96	26.01	52.02

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	3.15	3.14	3.06	2.78	2.48	2.38
Additional Paid-In Capital	552.34	549.62	539.64	486.11	476.52	335.08
Retained Earnings	-514.54	-501.02	-462.88	-419.63	-404.58	-402.11
Treasury Stock	-	-	-	-1.23	-1.34	-
Comprehensive Income & Other	-12.29	-10.82	-18.85	-17.49	-21.69	183.82
Shareholders' Equity	28.65	40.92	60.97	50.54	51.4	119.16
Total Liabilities & Equity	34.71	45.92	76.39	66.5	77.41	171.18

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	1.03	0.2	6.43	5.95	15.37	22.69
Net Cash (Debt)	29.09	40.79	63.37	51.47	52.81	104.99
Net Cash Growth	-47.61%	-35.63%	23.13%	-2.54%	-49.70%	1289.80%
Net Cash Per Share	0.18	0.26	0.43	0.39	0.44	0.95
Filing Date Shares Outstanding	159.69	159.62	159	140.01	124.74	116.73
Total Common Shares Outstanding	159.62	159.13	155.15	140	124.74	116.73
Working Capital	27.72	40.72	60.92	54.27	50.82	117.51
Book Value Per Share	0.18	0.26	0.39	0.36	0.41	1.02
Tangible Book Value	28.4	40.4	60.33	49.45	51.4	85.9
Tangible Book Value Per Share	0.18	0.25	0.39	0.35	0.41	0.74
Machinery	0.32	0.46	0.49	0.5	0.61	0.48
Leasehold Improvements	0.75	0.76	0.71	0.71	0.68	0.75